ArticleJournal of atherosclerosis and thrombosis2018

Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial).

Daisaku Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.